Synapsoft logo
AI Insights from Disclosures
Searching...
ViGenCell Inc. 308080
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
ViGenCell Inc. was established on February 1, 2013, as a biotech venture company whose main businesses are the research and development of new pharmaceuticals and the development and manufacture of immune cell therapy drugs, among others. Based on a cooperative model among industry, academia, and research institutes, the company has set a vision to grow into a specialized cell therapy company by utilizing platform technologies that treat various tumors and intractable diseases.
Representative Director Gi Pyeongseok
Founded February 1, 2013
Corporation Type KOSDAQ
Industry Classification Research and experimental development on natural sciences and engineering
Corporate number 11011-5059773
Business number 114-87-07720
Phone Number 02-3478-1686
Fax Number 02-533-7456
Company Address 66 Gasan-ro 9-gil, Geumcheon-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant